Protagonist Therapeutics
PTGX
#3534
Rank
A$4.51 B
Marketcap
$73.50
Share price
-4.43%
Change (1 day)
75.13%
Change (1 year)

Earnings for Protagonist Therapeutics (PTGX)

Earnings in 2024 (TTM): A$0.44 Billion

According to Protagonist Therapeutics 's latest financial reports the company's current earnings are A$0.43 Billion. , an increase over its 2023 earnings that were of -A$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protagonist Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 A$0.46 B-453.88%
2023 -A$0.14 Billion-38.02%
2022 -A$0.22 Billion1.47%
2021 -A$0.21 Billion93.62%
2020 -A$0.11 Billion-16.74%
2019 -A$0.13 Billion96.06%
2018 -A$65.71 Million7.48%
2017 -A$61.13 Million-0.59%
2016 -A$61.5 Million150.22%
2015 -A$24.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.24 Billion-151.14%๐Ÿ‡บ๐Ÿ‡ธ USA